N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide
C19H21N3O4S4 — CID 155947417
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide
N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide (PubChem CID 155947417) has the molecular formula C19H21N3O4S4 and a molecular weight of 483.66 g/mol. Its IUPAC name is N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide.
Molecular Properties
| Compound Name | N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide |
|---|---|
| PubChem CID | 155947417 |
| Molecular Formula | C19H21N3O4S4 |
| Molecular Weight | 483.66 g/mol |
| Exact Mass | 483.04 |
| IUPAC Name | N-[3-[4-(thiomorpholine-4-carbonyl)-1,3-thiazolidine-3-carbonyl]phenyl]thiophene-2-sulfonamide |
| SMILES | O=C(C1CSCN1C(=O)c1cccc(NS(=O)(=O)c2cccs2)c1)N1CCSCC1 |
| InChI | InChI=1S/C19H21N3O4S4/c23-18(22-13-28-12-16(22)19(24)21-6-9-27-10-7-21)14-3-1-4-15(11-14)20-30(25,26)17-5-2-8-29-17/h1-5,8,11,16,20H,6-7,9-10,12-13H2 |
| InChIKey | QOZSGWUOUIVYIC-UHFFFAOYSA-N |
| XLogP | 2.64 |
| TPSA | 86.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.66 |
| LogP ≤ 5 | 2.64 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155947417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.